← Zurück zu Insidertransaktionen
Scott L. Burrows
Gemeldet als: Burrows Scott L
Insider · Chief Financial Officer
Käufe
0
0 USD
Verkäufe
16
6.569.423 USD
Unternehmen
1
mit gemeldeten Geschäften
Letzte Aktivität
01.10.2026
16 Transaktionen gesamt
| Datum | Unternehmen | Position | Art | Volumen | Preis | Stückzahl | Seit Meldung |
|---|---|---|---|---|---|---|---|
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 21.427,53 USD | 93,57 USD | 229 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 285.449,45 USD | 92,95 USD | 3.071 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 193.032,00 USD | 91,92 USD | 2.100 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 135.405,00 USD | 90,27 USD | 1.500 | – |
| 01.10.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 53.442,00 USD | 89,07 USD | 600 | – |
| 30.09.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 1.573.075,00 USD | 89,89 USD | 17.500 | – |
| 02.09.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 1.629.029,20 USD | 89,35 USD | 18.232 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 17.808,00 USD | 89,04 USD | 200 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 177.468,48 USD | 88,03 USD | 2.016 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 381.890,24 USD | 87,11 USD | 4.384 | – |
| 01.09.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 77.625,00 USD | 86,25 USD | 900 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 9.710,00 USD | 97,10 USD | 100 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 221.490,00 USD | 96,30 USD | 2.300 | – |
| 03.08.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 485.571,00 USD | 95,21 USD | 5.100 | – |
| 25.06.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 871.400,00 USD | 87,14 USD | 10.000 | – |
| 25.06.2026 |
Spyre Therapeutics, Inc.
Chief Financial Officer
|
Chief Financial Officer | Verkauf | 435.600,00 USD | 87,12 USD | 5.000 | – |
Alle von „Burrows Scott L" gemeldeten Eigengeschäfte (Directors' Dealings) gemäß Art. 19 MAR bzw. den jeweiligen nationalen Pflichtmeldungen. Gleiche Personen können unter abweichenden Schreibweisen mehrfach geführt sein. „Seit Meldung" vergleicht den aktuellen Kurs (deutsche Handelsplätze, EUR) mit dem gemeldeten EUR-Preis der Transaktion — Meldungen in anderen Währungen bleiben ohne Angabe. Details in der Methodik.